Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV003151657 | SCV003840064 | uncertain significance | not specified | 2022-07-18 | no assertion criteria provided | clinical testing | DNA sequence analysis of the SLX4 gene demonstrated a sequence change, c.2615G>A, in exon 12 that results in an amino acid change, p.Gly872Asp. This sequence change does not appear to have been previously described in individuals with SLX4-related disorders and has also not been described in population databases such as ExAC and gnomAD. The p.Gly872Asp change affects a poorly conserved amino acid residue located in a domain of the SLX4 protein that is not known to be functional. The p.Gly872Asp substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Gly872Asp change remains unknown at this time. |